Age-related memory decline and longevity under treatment with selegiline
- 31 December 1994
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 55 (25-26), 2155-2163
- https://doi.org/10.1016/0024-3205(94)00396-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged miceLife Sciences, 1993
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Deprenyl reduces the death of motoneurons caused by axotomyJournal of Neuroscience Research, 1992
- Improvement of cognitive function by MAO-B inhibitor L-deprenyl in aged ratsPharmacology Biochemistry and Behavior, 1991
- Effects of a MAO-B Inhibitor in the Treatment of Alzheimer DiseaseEuropean Neurology, 1991
- Neuropsychological Effects of L-Deprenyl in Alzheimerʼs Type DementiaClinical Neuropharmacology, 1990
- The pharmacology of selegiline ((−)deprenyl). New aspectsActa Neurologica Scandinavica, 1989
- The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenylMechanisms of Ageing and Development, 1988
- L-Deprenyl in Alzheimer's DiseaseArchives of General Psychiatry, 1987
- Cognitive effects of l-deprenyl in Alzheimer's diseasePsychopharmacology, 1987